Antispastic medications should be considered when spasticity significantly impacts a cancer patient’s daily functioning and quality of life. They are particularly useful when spasticity causes pain, interferes with mobility, or hinders the effectiveness of other therapeutic interventions. These medications should be prescribed by a healthcare professional after a thorough assessment.